We would like to congratulate the team at FluoretiQ Limited, which is part of the Deepbridge Life Sciences EIS portfolio, for being the start-up pitch winner during the 4th annual AMR Conference.

The AMR conference’s website describes the #AMRConference as “a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market”.

To read the full winner’s interview, please click here.

By following this link, you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites. 

To find out more about FluoretiQ please click here.